Fibrobiologics

IN THE PRESS

Business

FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids

April 25, 2024

·

4 min read

Policy

FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office

April 11, 2024

·

4 min read

Lone Star Bio

FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA

April 4, 2024

·

5 min read

Lone Star Bio

FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment

March 19, 2024

·

4 min read

Lone Star Bio

FibroBiologics to Present at Advanced Wound Care Summit USA

March 13, 2024

·

4 min read

Business

FibroBiologics Appoints Ruben A. Garcia as General Counsel

March 6, 2024

·

4 min read

Lone Star Bio

FibroBiologics Files 2023 Form 10-K Annual Report

February 29, 2024

·

1 min read

Lone Star Bio

FibroBiologics to Present Preclinical and Clinical Data at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum

February 20, 2024

·

6 min read

Drug Development

FibroBiologics Presents Preclinical Data at the 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory Diseases

February 13, 2024

·

5 min read

Lone Star Bio

FibroBiologics Announces Three United States Patents for Fibroblast Technology

February 8, 2024

·

4 min read

JOBS